ATLANTA — The Advisory Committee on Immunization Practices is meeting here this week. The committee is composed of experts who guide policy on how vaccines should be used in the United States. The group’s votes have real-world implications on the vaccines that are available to Americans. They also have implications for the companies that make the vaccines ACIP reviews.

On Wednesday, the committee voted to update its recommendations on influenza vaccines to be used in the upcoming 2017-18 season. There were winners and losers.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!

GET STARTED

What is it?

STAT Plus is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • Online intelligence briefings
  • Frequent opportunities to engage with veteran beat reporters and industry experts
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Leave a Comment

Please enter your name.
Please enter a comment.

  • Immunologists please chime in. One reason that Flu Mist will always underperform the flu shot is that the influenza strains used to make the shot are customized each year based on recommendations of CDC and WHO. In contrast the same strains of Influenza Types A and B are used to make Flu Mist each year despite the well known fact that viral strains mutate all the time.

    • Hi there! Did my Ph.D. in influenza vaccinology 🙂

      FluMist uses the same WHO-recommended strains as the injected vaccine. Both vaccines use modified viruses that combine parts of a very immunogenic strain (one that activates your immune system) with surface proteins from the circulating strains that year. The virus for FluMist is attenuated (weakened) by adapting it to a non-human species, while the injected vaccine is inactivated by heat or chemicals. Same strains in each vaccine though!

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy